CAP-accredited provider of gene expression–based diagnostic tests for oncology that combine molecular biology and AI to produce actionable molecular classifiers guiding clinicians and reducing unnecessary procedures and costs. Products include a microRNA/DNA classifier for indeterminate thyroid nodules that markedly reduces unnecessary surgeries and an mRNA-based tumor-origin classifier to inform treatment decisions for metastatic cancers of unknown primary.